-
公开(公告)号：US09649343B2
公开(公告)日：2017-05-16
申请号：US15261319
申请日：2016-09-09
IPC分类号： A61K35/38 , A61K35/74 , A61K45/06 , A61K9/19 , A61K35/37 , A61K35/24 , A61K35/741 , A61K9/00 , A61K35/742 , A61K9/16 , A61K47/08 , A61K47/26 , C12N1/20 , A61K35/00
CPC分类号： A61K35/37 , A61K9/0053 , A61K9/16 , A61K9/1617 , A61K9/1623 , A61K35/24 , A61K35/74 , A61K35/741 , A61K35/742 , A61K45/06 , A61K47/08 , A61K47/26 , A61K2035/11 , Y02A50/473 , Y02A50/475 , A61K2300/00
摘要： The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
-
公开(公告)号：US10849936B2
公开(公告)日：2020-12-01
申请号：US16313791
申请日：2017-07-03
摘要： The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
-
公开(公告)号：US20160375063A1
公开(公告)日：2016-12-29
申请号：US15261319
申请日：2016-09-09
CPC分类号： A61K35/37 , A61K9/0053 , A61K9/16 , A61K9/1617 , A61K9/1623 , A61K35/24 , A61K35/74 , A61K35/741 , A61K35/742 , A61K45/06 , A61K47/08 , A61K47/26 , A61K2035/11 , Y02A50/473 , Y02A50/475 , A61K2300/00
摘要： The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
-
公开(公告)号：US10286011B2
公开(公告)日：2019-05-14
申请号：US15594087
申请日：2017-05-12
IPC分类号： A61K35/38 , A61K35/74 , A61K45/06 , A61K9/19 , A61K35/37 , A61K35/24 , A61K35/741 , A61K9/00 , A61K35/742 , A61K9/16 , A61K47/08 , A61K47/26 , A61K35/00
摘要： The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
-
公开(公告)号：US10028980B2
公开(公告)日：2018-07-24
申请号：US15173134
申请日：2016-06-03
IPC分类号： A61K35/74 , A61K35/742 , A61K9/00 , A61K35/37 , A61K35/24 , A61K35/741 , A61K9/16 , A61K47/08 , A61K47/26 , A61K45/06 , A61K35/00
摘要： The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
-
公开(公告)号：US20160279176A1
公开(公告)日：2016-09-29
申请号：US15173134
申请日：2016-06-03
IPC分类号： A61K35/74 , A61K9/00 , A61K35/24 , A61K35/742
CPC分类号： A61K35/37 , A61K9/0053 , A61K9/16 , A61K9/1617 , A61K9/1623 , A61K35/24 , A61K35/74 , A61K35/741 , A61K35/742 , A61K45/06 , A61K47/08 , A61K47/26 , A61K2035/11 , Y02A50/473 , Y02A50/475 , A61K2300/00
摘要： The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
摘要翻译： 本发明提供了包含人类粪便提取物的组合物和使用这些组合物的方法，包括用于替代或补充或修饰受试者的结肠微生物群的方法，以及用于治疗患者的疾病，病理状况和/或医源性病症的方法 结肠。
-
公开(公告)号：US11819523B2
公开(公告)日：2023-11-21
申请号：US17098243
申请日：2020-11-13
CPC分类号： A61K35/74 , A01N1/02 , A61K9/0053 , A61K9/1623 , A61K9/1682 , A61K9/19 , A61K9/2095 , A61K31/43 , A61P31/04
摘要： The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
-
公开(公告)号：US11801269B2
公开(公告)日：2023-10-31
申请号：US17852314
申请日：2022-06-28
IPC分类号： A61K35/37 , A61K35/24 , A61K35/74 , A61K35/741 , A61K9/00 , A61K35/742 , A61K9/16 , A61K47/08 , A61K47/26 , A61K45/06 , A61K35/00
CPC分类号： A61K35/37 , A61K9/0053 , A61K9/16 , A61K9/1617 , A61K9/1623 , A61K35/24 , A61K35/74 , A61K35/741 , A61K35/742 , A61K45/06 , A61K47/08 , A61K47/26 , A61K2035/11 , Y02A50/30 , A61K35/74 , A61K2300/00 , A61K35/24 , A61K2300/00
摘要： The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
-
公开(公告)号：US20220339203A1
公开(公告)日：2022-10-27
申请号：US17852314
申请日：2022-06-28
IPC分类号： A61K35/37 , A61K35/24 , A61K35/74 , A61K35/741 , A61K9/00 , A61K35/742 , A61K9/16 , A61K47/08 , A61K47/26 , A61K45/06
摘要： The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
-
公开(公告)号：US10286012B2
公开(公告)日：2019-05-14
申请号：US15594319
申请日：2017-05-12
IPC分类号： A61K35/38 , A61K35/74 , A61K45/06 , A61K9/19 , A61K35/37 , A61K35/24 , A61K35/741 , A61K9/00 , A61K35/742 , A61K9/16 , A61K47/08 , A61K47/26 , A61K35/00
摘要： The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.042 秒)
